Ozmosi | ferric oxide polymaltose complexes Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

ferric oxide polymaltose complexes

Alternative Names: ferric oxide polymaltose complexes
Clinical Status: Inactive
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action:

Novel Mechanism: No

Modality: Unknown

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Australia | Belgium | Bosnia | Bulgaria | Czech | Dominican Republic | Ecuador | Finland | Greece | Hungary | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Malaysia | Malta | Morocco | Netherlands | Pakistan | Peru | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | Sweden | Switzerland | Turkey | Ukraine | Uruguay | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company Founding Year: None
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

Recent News Events

Date

Type

Title